Details for New Drug Application (NDA): 063107
✉ Email this page to a colleague
NDA 063107 describes EMGEL, which is a drug marketed by Altana and is included in one NDA. Additional details are available on the EMGEL profile page.
The generic ingredient in EMGEL is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
The generic ingredient in EMGEL is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 063107
| Tradename: | EMGEL |
| Applicant: | Altana |
| Ingredient: | erythromycin |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 063107
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | GEL;TOPICAL | Strength | 2% | ||||
| Approval Date: | Aug 23, 1991 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
